The T cells stably expressing anti-EpCAM CAR displayed a high cell lysis activity towards EpCAM-positive ovarian cancer cells, being able to kill 69.2 ± 8.8% of SKOV3-Luc tumor cells, 68.7 ± 4.8% of CAOV-3 cells, and 91.5 ± 2.6% SW626 cells at an effector to target (E:T) ratio of 40:1 (Figure 3B). Here, EPCAM is linked to neoplasm.